Private equity firm TA Associates has completed a growth equity investment in CCRM, a leading provider network of fertility treatment services with locations in Colorado, California, Minnesota, Texas and Toronto, Canada. Financial terms of the transaction have not been disclosed.
With a reputation for world-class physicians, facilities and laboratories, CCRM operates a network of fertility clinics providing a wide variety of treatments from basic infertility care to advanced in vitro fertilisation (IVF). Founded by Dr William Schoolcraft, the CCRM network includes the Colorado Center for Reproductive Medicine, considered one of the nation’s premier fertility centres. As a result of CCRM’s significant and ongoing investment in research and development, the company achieves industry leading IVF success rates. CCRM is headquartered in Lone Tree, Colorado.
“We have known the team at TA Associates for several years, and have built a positive, collaborative rapport, and we are excited to welcome the firm as an investor,” says William Schoolcraft, MD, Founder, CCRM. “Similar to CCRM, we believe that TA has deep experience and a track record of success that bodes well for the future growth of our company. With TA’s support, we will continue our work of combining professional care, research and development, and best laboratory practices in pursuit of optimal outcomes for our patients.”
“CCRM has proven excellence in pregnancy success rates,” says Jennifer M Mulloy (pictured), a Managing Director at TA Associates who will join the CCRM Board of Directors. “We believe this success is due to high quality physician partners, extensive research and development efforts, and the company’s resulting best practices in the laboratory. We are very pleased to partner with CCRM to continue to expand the best practices from the existing network to additional locations.”
“Partnering with TA Associates is critical to our multi-year effort to expand our footprint in North America and around the world,” says Jon Pardew, President and Chief Executive Officer, CCRM. “With TA’s support, we will continue to broaden our network of leading fertility laboratories. In addition, the highly fragmented US IVF market, with approximately 500 clinics, presents possible future M&A opportunities for CCRM.”
“Marketdata Enterprises estimates annual expenditures related to fertility treatment in the United States at USD4 billion, and the Centers for Disease Control estimates that approximately 12% of women of reproductive age in the United States, or five to six million, engage in infertility-related medical appointments each year,” says Ethan K Liebermann, a Senior Vice President at TA Associates who will also join the CCRM Board of Directors. “These figures reflect the marked trend over the last several decades of women seeking to have children later in life. We are confident that given these industry dynamics, and CCRM’s superior clinical outcomes, the company will see continued growth.”
